May 24, 2007 (San Diego) — A recent study found that among patients in a psychiatric hospital, the atypical antipsychotic quetiapine (Seroquel, AstraZeneca), which is approved for schizophrenia and ...
Augmentation was more effective with quetiapine than lithium for treatment-resistant depression in a pragmatic trial. Quetiapine also improved quality-adjusted life years more than lithium. The ...
Researchers examined the effects of combining quetiapine treatment with CBT in individuals with mood disorders and patient outcomes for suicide risk and coping style.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results